Thomas Martens, MD*

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Dexcom
    Topic: 
    Research
    Date added: 
    07/27/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Dexcom
    Topic: 
    Advisory Board
    Date added: 
    07/27/2022
    Relationship end date: 
    12/31/2021
  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Abbott Diabetes Care
    Topic: 
    Research
    Date added: 
    07/27/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Medtronic
    Topic: 
    Research
    Date added: 
    07/27/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Insulet
    Topic: 
    Research
    Date added: 
    07/27/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Novo Nordisk
    Topic: 
    Research
    Date added: 
    07/27/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Lilly
    Topic: 
    Research
    Date added: 
    07/27/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Medscape
    Topic: 
    Speaking
    Date added: 
    07/27/2022
    Relationship end date: 
    06/25/2021
  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Medscape
    Topic: 
    Advisory Board
    Date added: 
    07/27/2022
    Relationship end date: 
    12/31/2021
  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Sanofi
    Topic: 
    Speaking
    Date added: 
    07/27/2022
    Relationship end date: 
    05/19/2022

Pages

Return to Clinical Diabetes Management - October 2023